India updates export regulations; AAIPharma continues exec suite turnover;

> India will announce new regulations for pharmaceutical exports to clearly identify product origin and manufacturer in an attempt to "tackle the campaigns on the quality of Indian generics and their wrongful identification with counterfeit drugs." Article

> AAIPharma Services, which last month announced the naming of Patrick Walsh as CEO, has appointed Tim Martin as executive VP for sales and marketing, and Rob Goshert as VP for corporate accounts.  AAIPharma Services release

> Takeda Pharma will build a pharma manufacturing plant in Hikari City, Japan, on the premises of its existing Hikari Plant located in Japan. Story

> Glenn Kazo has been named president at Prolong Pharmaceuticals in South Plainfield, NJ. Prolong release

> Protein production service supplier Laureate Pharma has appointed Steven Johnson to the post of VP for business development. Laureate release

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.